Baht 24.46 million, a decrease of 62.93% compared to 2017. Final earnings per share resulted at Baht 1.15. Total Revenues 2018 2017 Change (Million Baht) (Million Baht) (%) Sales 2,020.63 2,147.64 (5.91
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
margin (%) 65.5% 62.6% (2.9%) EBITDA margin (%) 31.6% 26.4% (5.2%) Net profit margin (%) 20.9% 5.9% (15.0%) Number of branches as at Mar 31 36 39 8% Change +/(-)Q1/19 Q1/20 Operating highlight in Q1/2020
services increase and the financing cost increase. Thus, the details of the Company’s performance are explained as follows: 2017 2018 Change MB % MB % MB % Rental and Service Income 708.0 94.9% 628.7 86.9
. Statement of Comprehensive Income Total Revenues (Million Baht) Quarterly Change 1/2019 1/2018 % Sales Domestic Sales 88.4 106.6 (17.1) Export Sales 295.8 295.2 0.2 Total Sales 384.2 401.8 (4.4) Foreign
revenue of THB 202.23 million and THB 190.24 million, respectively. This is equal to a decline of 5.93% year on year. Domestic sales revenue dropped 15.94% from the same period of the previous year due to
follows: Income Statement For the three-month ended March 31 Change Unit: Million Baht 2018 2017 Amount % Revenues from construction services and sales of construction materials 7,389.74 8,064.50 (674.76
Company’s operating performance in 2017 and 2016 is shown in the following table: FY2017 FY2016 % Change FY2015 % Change [Amount in Baht Million] Y-o-Y Y-o-Y [2017 VS. 2016] [2016 VS. 2015] Sales Revenue
partially offset by higher sales volume of all main products as a result of stable operation. The share of domestic and export sales has no significant change comparing with the previous year. * Note Please
, compared with the same period last year, net profit increased 25.06 million baht, accounting for 149.3 percent. This is a change of more than 20 percent, the major reasons are as follows: The company has